» Articles » PMID: 24015313

Newcastle Disease Virus Fusion Protein is the Major Contributor to Protective Immunity of Genotype-matched Vaccine

Overview
Journal PLoS One
Date 2013 Sep 10
PMID 24015313
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Virulent strains of Newcastle disease virus (NDV) can cause devastating disease in chickens worldwide. Although the current vaccines are substantially effective, they do not completely prevent infection, virus shedding and disease. To produce genotype-matched vaccines, a full-genome reverse genetics system has been used to generate a recombinant virus in which the F protein cleavage site has been changed to that of avirulent vaccine virus. In the other strategy, the vaccines have been generated by replacing the F and HN genes of a commercial vaccine strain with those from a genotype-matched virus. However, the protective efficacy of a chimeric virus vaccine has not been directly compared with that of a full-genome virus vaccine developed by reverse genetics. Therefore, in this study, we evaluated the protective efficacy of genotype VII matched chimeric vaccines by generating three recombinant viruses based on avirulent LaSota (genotype II) strain in which the open reading frames (ORFs) encoding the F and HN proteins were replaced, individually or together, with those of the circulating and highly virulent Indonesian NDV strain Ban/010. The cleavage site of the Ban/010 F protein was mutated to the avirulent motif found in strain LaSota. In vitro growth characteristics and a pathogenicity test indicated that all three chimeric viruses retained the highly attenuated phenotype of the parental viruses. Immunization of chickens with chimeric and full-length genome VII vaccines followed by challenge with virulent Ban/010 or Texas GB (genotype II) virus demonstrated protection against clinical disease and death. However, only those chickens immunized with chimeric rLaSota expressing the F or F plus HN proteins of the Indonesian strain were efficiently protected against shedding of Ban/010 virus. Our findings showed that genotype-matched vaccines can provide protection to chickens by efficiently preventing spread of virus, primarily due to the F protein.

Citing Articles

Superior Efficacy of Apathogenic Genotype I (V4) over Lentogenic Genotype II (LaSota) Live Vaccines against Newcastle Disease Virus Genotype VII.1.1 in Pathogen-Associated Molecular Pattern-H9N2 Vaccinated Broiler Chickens.

Elbestawy A, Ellakany H, Sedeik M, Gado A, Abdel-Latif M, Noreldin A Vaccines (Basel). 2023; 11(11).

PMID: 38005970 PMC: 10674370. DOI: 10.3390/vaccines11111638.


The production of Newcastle disease virus-like particles in as potential vaccines.

Smith T, OKennedy M, Ross C, Lewis N, Abolnik C Front Plant Sci. 2023; 14:1130910.

PMID: 36875611 PMC: 9978804. DOI: 10.3389/fpls.2023.1130910.


Genetic diversity of Newcastle disease viruses circulating in wild and synanthropic birds in Ukraine between 2006 and 2015.

Goraichuk I, Gerilovych A, Bolotin V, Solodiankin O, Dimitrov K, Rula O Front Vet Sci. 2023; 10:1026296.

PMID: 36742982 PMC: 9893288. DOI: 10.3389/fvets.2023.1026296.


investigation of the antiviral activity of propolis and chitosan nanoparticles against the genotype VII Newcastle disease virus.

Alkhalefa N, Khaliel S, Tahoon A, Shaban H, Magouz A, Ghabban H Front Vet Sci. 2022; 9:947641.

PMID: 36090167 PMC: 9453155. DOI: 10.3389/fvets.2022.947641.


Single-Dose Vaccination of Recombinant Chimeric Newcastle Disease Virus (NDV) LaSota Vaccine Strain Expressing Infectious Bursal Disease Virus (IBDV) VP2 Gene Provides Full Protection against Genotype VII NDV and IBDV Challenge.

Qiao Q, Song M, Song C, Zhang Y, Wang X, Huang Q Vaccines (Basel). 2021; 9(12).

PMID: 34960229 PMC: 8704353. DOI: 10.3390/vaccines9121483.


References
1.
Aldous E, Fuller C, Mynn J, Alexander D . A molecular epidemiological investigation of isolates of the variant avian paramyxovirus type 1 virus (PPMV-1) responsible for the 1978 to present panzootic in pigeons. Avian Pathol. 2004; 33(2):258-69. DOI: 10.1080/0307945042000195768. View

2.
Xiao S, Paldurai A, Nayak B, Samuel A, Bharoto E, Prajitno T . Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of Indonesia. J Virol. 2012; 86(10):5969-70. PMC: 3347286. DOI: 10.1128/JVI.00546-12. View

3.
Cosset F, Bouquet J, Drynda A, Chebloune Y, Kohen G, Nigon V . Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein. Virology. 1991; 185(2):862-6. DOI: 10.1016/0042-6822(91)90560-x. View

4.
Karaca K, Sharma J, Winslow B, Junker D, Reddy S, Cochran M . Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses. Vaccine. 1998; 16(16):1496-503. DOI: 10.1016/s0264-410x(97)00295-8. View

5.
Boursnell M, Green P, Samson A, Campbell J, Deuter A, Peters R . A recombinant fowlpox virus expressing the hemagglutinin-neuraminidase gene of Newcastle disease virus (NDV) protects chickens against challenge by NDV. Virology. 1990; 178(1):297-300. DOI: 10.1016/0042-6822(90)90408-j. View